AzTrials
AzTrials

Injury;SportsI-THINCNCT05459363

Neuromuscular Cognitive Training

A study testing I-THINC in people with Injury;Sports, run by Ke'La H Porter at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This project will utilize a quasi-experimental, multiple baseline pretest-posttest design where participants will complete postural stability assessments, physical performance assessments, and questionnaires to evaluate perceptions toward injury prevention before and after completing a 6-week neuromuscular-cognitive… Read more about this study

Who is it for?
Ages 18 to 30 yearsHealthy volunteers can take part
Conditions the study is for
Injury;Sports
What is being tested?
I-THINC
Could I receive a placebo?
No, everyone receives an active treatment
How many people
10 participants
Where
1 siteUnited States
Study dates
23 Aug 2022to 15 Oct 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 30 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • healthy adults from the University of Kentucky varsity tennis programs

Who cannot join

  • not medically cleared for participation

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Sports Medicine Research Institute

    Lexington, Kentucky, 40506

Other trials in United States

About this study

Official title: Improved Training Happens With Integrated Neuromuscular and Cognitive Challenge

This project will utilize a quasi-experimental, multiple baseline pretest-posttest design where participants will complete postural stability assessments, physical performance assessments, and questionnaires to evaluate perceptions toward injury prevention before and after completing a 6-week neuromuscular-cognitive prevention program.

Read the detailed description

The I-THINC program will address aspects of cognition (i.e., reaction time/processing speed, working memory, cognitive flexibility, inhibitory control, attention, and dual-tasking) while completing common movement patterns utilized in tennis (i.e., lateral shuffle, rapid acceleration/deceleration, and postural stability). The proposed program will take place in the participants training facility. The program will be implemented twice per week for six weeks (12 sessions) with each session lasting 20 minutes. To add variety, there will be two complementary programs (A and B) comprising of four exercises increasing in complexity every two weeks. Each week participants will complete Program A during the first session and Program B during the second session.Exercises will progressively challenge cognitive and physical demand. Exercises were designed to address the most common injuries in tennis.

Conditions
Injury;Sports
Being tested
I-THINC
Keywords
injury prevention, cognition, physical performance, postural stability, neuromuscular
Medical subject headings
Athletic Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • I-THINCOther

    Improved Training Happens with Integrated Neuromuscular and Cognitive Challenge (I-THINC) is an injury prevention program. It will be used to integrate cognitive tasks with traditional sports injury prevention approaches that focus on balance, agility, and neuromuscular control.

Study groups in NCT05459363
Study groupRoleWhat they receive
Varsity AthletesExperimentalHealthy adults recruited from the University of Kentucky varsity tennis programs.
Receives: Other: I-THINC

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in single task static postural stability

    Single task static postural stability will be assessed with an Accusway Plus force plate.

    Measured: 6 weeks (baseline, one week after baseline, and immediately following the 6 week intervention)

  2. Change in dual task postural stability

    Dual task static postural stability will be assessed with an Accusway Plus force plate while completeing an upper extremity reaction time on the Dynavision D2.

    Measured: 6 weeks (baseline, one week after baseline, and immediately following the 6 week intervention)

  3. Change in dynamic postural control

    Dynamic postural control will be assessed with the single leg hop.

    Measured: 6 weeks (baseline, one week after baseline, and immediately following the 6 week intervention)

  4. Change in dual task dynamic postural control

    Dynamic postural control will be assessed with the single leg hop. An additional cognitive task - responding to LED color cues - will be added.

    Measured: 6 weeks (baseline, one week after baseline, and immediately following the 6 week intervention)

  5. Change in speed, power and agility (single measure)

    Speed, power and agility will be measured using the Run Decide Test.

    Measured: 6 weeks (baseline, one week after baseline, and immediately following the 6 week intervention)

  6. Change in reactive agility

    Reactive agility will be assessed with the 4x4 box drill.

    Measured: 6 weeks (baseline, one week after baseline, and immediately following the 6 week intervention)

  7. Change in lower extremity reaction time

    Lower extremity reaction time will be assessed with the lower extremity reaction test, deactivating sensors as quickly as possible with their foot.

    Measured: 6 weeks (baseline, one week after baseline, and immediately following the 6 week intervention)

  8. Change in HBMS

    Health Belief Model Scale (HBMS) is used to assess behavioral determinants of exercise related injury prevention programs and is comprised of six subscales: susceptibility, severity, benefits, barriers, cues to action, and self-efficacy. Participants rate how strongly they agree or disagree with the statements on a Likert scale ranging from 3 to -3, with a 3 indicating strongly agree and -3 indicating strongly disagree. Positive responses indicate a positive perception towards injury prevention programs, except the barrier subscale where positive responses indicate a negative perception towards injury prevention programs.

    Measured: 6 weeks (baseline, one week after baseline, and immediately following the 6 week intervention)

  9. Participant engagement

    The participant engagement survey will contain Likert Scale (1-5) questions to provide a quantitative analysis of satisfaction with the program. A 1 indicates strongly disagree and a 5 indicates strongly agree. The range is 7-35, and higher scores indicate increased engagement.

    Measured: at 6 weeks

  10. Compliance

    Compliance will be based on the percentage of sessions attended by participants.

    Measured: 6 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Jul 2022
  2. Study start23 Aug 2022
  3. Primary completion15 Oct 2022
  4. Study completion15 Oct 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
10 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05459363
Sponsor's protocol ID
76666
Acronym
I-THINC
Status last verified
Jun 2024
First submitted
12 Jul 2022
Last updated
4 Jun 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing I-THINC in people with Injury;Sports, run by Ke'La H Porter at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 4 Jun 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in single task static postural stability (time frame: 6 weeks (baseline, one week after baseline, and immediately following the 6 week intervention)). The study lists 10 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Jun 2024.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in